Viewing Study NCT06022757


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2025-12-25 @ 4:40 PM
Study NCT ID: NCT06022757
Status: RECRUITING
Last Update Posted: 2024-02-23
First Post: 2023-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)
Sponsor: Evopoint Biosciences Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module